Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Regenerative Medicine|May 9, 2008
The strong financial case for regenerative medicine and the regen industryChris Mason, Peter DunnillRegenerative Medicine|November 12, 2009
Assessing the value of autologous and allogeneic cells for regenerative medicineChris Mason, Peter DunnillJournal of Public Health Policy|August 25, 2007
Commentary: From scarcity to abundance: pandemic vaccines and other agents for "have not" countriesDavid S Fedson, Peter DunnillThe Permanente Journal|April 5, 2011
New approaches to confronting an imminent influenza pandemicDavid S Fedson, Peter DunnillBiotechnology Progress|February 2, 2002
Separation characteristics of liquid nematode cultures and the design of recovery operationsJohn M Young, Peter Dunnill, Jeremy D PearceBiotechnology Progress|December 3, 2005
Bioprocess engineering issues that would be faced in producing a DNA vaccine at up to 100 m3 fermentation scale for an influenza pandemicMike Hoare, M Susana Levy, Daniel G Bracewell, et al.Tissue Engineering|May 6, 2006
Behavior of adult human mesenchymal stem cells entrapped in alginate-GRGDY beadsJulia F Markusen, Christopher Mason, Dearbhla A Hull, et al.Pageof 1